Humedix Co Ltd (200670) - Total Liabilities
Based on the latest financial reports, Humedix Co Ltd (200670) has total liabilities worth ₩23.40 Billion KRW (≈ $15.86 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 200670 cash flow conversion to assess how effectively this company generates cash.
Humedix Co Ltd - Total Liabilities Trend (2015–2024)
This chart illustrates how Humedix Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 200670 financial resilience to evaluate the company's liquid asset resilience ratio.
Humedix Co Ltd Competitors by Total Liabilities
The table below lists competitors of Humedix Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Polyram Plastic Industries Ltd
TA:POLP
|
Israel | ILA543.64 Million |
|
SIM Acquisition Corp. I Class A Ordinary Shares
NASDAQ:SIMA
|
USA | $11.25 Million |
|
Profound Medical Corp
TO:PRN
|
Canada | CA$102.04 Million |
|
Kogan.com Ltd
AU:KGN
|
Australia | AU$129.62 Million |
|
Metro Mining Limited
F:6ME
|
Germany | €202.60 Million |
|
Shandong Longertek Technology Co Ltd
SHE:300594
|
China | CN¥1.09 Billion |
Liability Composition Analysis (2015–2024)
This chart breaks down Humedix Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Humedix Co Ltd (200670) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 9.22 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.09 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.08 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Humedix Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Humedix Co Ltd (2015–2024)
The table below shows the annual total liabilities of Humedix Co Ltd from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩21.22 Billion ≈ $14.38 Million |
-3.17% |
| 2023-12-31 | ₩21.91 Billion ≈ $14.85 Million |
-75.10% |
| 2022-12-31 | ₩88.03 Billion ≈ $59.65 Million |
-2.05% |
| 2021-12-31 | ₩89.87 Billion ≈ $60.90 Million |
+61.70% |
| 2020-12-31 | ₩55.58 Billion ≈ $37.67 Million |
+111.18% |
| 2019-12-31 | ₩26.32 Billion ≈ $17.84 Million |
+18.86% |
| 2018-12-31 | ₩22.14 Billion ≈ $15.00 Million |
+1.46% |
| 2017-12-31 | ₩21.82 Billion ≈ $14.79 Million |
-1.02% |
| 2016-12-31 | ₩22.05 Billion ≈ $14.94 Million |
+261.59% |
| 2015-12-31 | ₩6.10 Billion ≈ $4.13 Million |
-- |
About Humedix Co Ltd
Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetics, and health functional food products. It is also involved in the manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to H… Read more